Drug class: Second-generation Antihistamine
- A new selective histamine H1 receptor and platelet-activating factor antagonist, shown to be an effective and generally well-tolerated treatment for allergic rhinitis and chronic urticaria.
- A suitable first line anti-histamine that is used to improve the symptoms of Allergic rhinitis.
- Safe with a low incidence of side effects and effectively controls persistent allergic rhinitis.
- Used for the management of diseases with allergic inflammatory conditions, such as seasonal and perennial rhinitis and helps improve the nasal and non-nasal symptoms.